As both PKCδ and integrin αVβ3 can function as upstream activators of ERK [11], a pathway essential for survival when cells lose their attachment to the ECM [23], we explored the contribution of ERK activation to the transformed growth of K-ras mutant NSCLC cells. The gene discussed is KRAS; the disease is non-small cell lung carcinoma.